PPT-Rationale for New Drugs for Tuberculosis

500000 cases annually of MDR TB Second line treatment toxic and weak 15 of TB is HIVrelated Drugdrug interactions problematic 15 of TB is in children Formulations

drugs drug regimen treatment drug drugs treatment regimen development mdr compound effects 2012 access 000 regimens trial phase potential clinical side endpoints

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/384557" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Rationale for New Drugs for Tuberculosis" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.